Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Expert Review of Pharmacoeconomics & Outcomes Research|January 17, 2017
The insights of health and welfare professionals on hurdles that impede economic evaluations of welfare interventionsJ Schepers, J Plaete, I De Bourdeaudhuij, et al.
International Journal of Clinical Practice|February 1, 2007
Clinical and economic analysis of antimicrobial therapy of chronic obstructive pulmonary disease exacerbationsS Simoens, M Decramer, S De Coster, et al.
Methods (San Diego, Calif.)|August 23, 2012
Improving biological relevancy of transcriptional biomarkers experiments by applying the MIQE guidelines to pre-clinical and clinical trialsM Dooms, A Chango, E Barbour, et al.
Allergy|June 27, 2014
Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN reviewT Zuberbier, J Lötvall, S Simoens, et al.
Orphanet Journal of Rare Diseases|May 27, 2016
Quantifying benefit-risk preferences for new medicines in rare disease patients and caregiversT Morel, S Aymé, D Cassiman, et al.
Scottish Medical Journal|June 24, 2004
What does GP out of hours care cost? An analysis of different models of out of hours care in ScotlandA Scott, S Simoens, D Heaney, et al.
Drug Discovery Today|March 23, 2025
Drug-device combinations in rare diseases: Challenges and opportunitiesE A Tataru, M Dooms, C Gonzaga-Jauregui, et al.
Human Reproduction (Oxford, England)|July 13, 2013
The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional surveyA A De Graaff, T M D'Hooghe, G A J Dunselman, et al.
British Journal of Cancer|October 13, 2012
Incidence and drug treatment of emotional distress after cancer diagnosis: a matched primary care case-control studyF Desplenter, C Bond, M Watson, et al.
Expert Review of Medical Devices|September 20, 2024
Orphan and paediatric medical devices in Europe: recommendations to support their availability for on-label and off-label clinical indicationsTom Melvin, Marc M Dooms, Berthold Koletzko, et al.
Pageof 5